LDS/Medical Tests/Ceruloplasmin, Serum

Ceruloplasmin, Serum

Ceruloplasmin is a protein that is produced in the liver and is the major transporter of copper in the body. About 90% - 95% of the copper in the blood is bound to ceruloplasmin. Ceruloplasmin transports copper from the liver to the plasma where it can travel to tissues requiring it. When there is a congenital decrease in ceruloplasmin, toxic amounts of copper will accumulate in the liver, brain, cornea and kidneys. This is a disorder called Wilson’s disease (aka hepatolenticular degeneration), which is an autosomal recessive defect in hepatic metallothionein resulting in decreased production of ceruloplasmin. Decreased ceruloplasmin and increased liver copper confirms a diagnosis of Wilson’s disease. Another disease associated with decreased levels of ceruloplasmin is Menke’s disease. Menke’s disease is an X-linked recessive genetic disorder which results in decreased absorption of copper with resultant decreased ceruloplasmin synthesis.

Decreases in ceruloplasmin can also be caused by non-genetic reasons such as malnutrition, malabsorption, liver failure or overdose of Vitamin C. Significant decrease in ceruloplasmin levels are also seen in aceruloplasminemia. This is an autosomal recessive disorder that is caused by a mutation in the ceruloplasmin gene which results in decreased synthesis of ceruloplasmin. Ceruloplasmin is also involved in the metabolism and maintenance of iron. It catalyzes the oxidation of ferrous iron to ferric iron. When the mutation is present, iron will accumulate in the pancreas, liver, and brain and cause degeneration of those organs. Increased levels of ceruloplasmin are seen in acute inflammation (it is an acute phase reactant), pregnancy, rheumatoid arthritis, lymphoma and other disorders. Although ceruloplasmin levels are useful in diagnosing many disorders, it is the key test in diagnosing Wilson’s disease.

  • Diagnosis of Wilson’s disease
  • Aiding in evaluation of neurodegenerative disorders other than Wilson’s disease
  • Diagnosis of Menke’s disease
  • As an aid in diagnosis of aceruloplasminemia
  • Aiding in diagnosing copper deficiency due to malnutrition or malabsorption

Increased in:

  • Acute and chronic inflammation
  • Some neoplasms such as certain carcinomas, leukemias, non-Hodgkin and Hodgkin lymphomas
  • Some drugs such as contraceptives, phenytoin
  • Pregnancy
  • Rheumatoid arthritis

Decreased in:

  • Wilson’s disease (hepatolenticular degeneration)
  • Some CNS diseases other than Wilson’s disease
  • Some liver diseases other than Wilson’s disease
  • Malabsorption and malnutrition
  • Primary biliary cirrhosis
  • Aceruloplasminemia
  • Nephrotic syndrome
  • Severe copper deficiency
  • Menke’s disease
  • Contraceptives

Note: Levels > 30mg/dL will exclude the diagnosis of Wilson’s disease; however, hypoceruloplasminemia alone is insufficient to make the diagnosis.

Age Group mg/dL umol/L
1d - 3 mo 5-18 50-180
6-12 m 33-43 330-430
12m-7yr 24-56 240-560
>7 18-45 180-450

During pregnancy, levels gradually increase and can peak at values 2-3x normal.

Spectrophotometric, immunodiffusion, nephelometry, and turbidimetry

Serum (SST). 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Copper Serum, Copper Urine, Liver Profile (see liver profile), CBC, Comprehensive Metabolic Panel, Iron Studies, Ferritin.
Same day.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Aliment Pharmacol Ther. 2004;19:157. [PMID: 14723607]
  • J Clin Gastroenterol. 2006 Nov-Dec;40(10):936-41 [PMID: 10632959]
  • Lancet. 2007;369:397. [PMID: 17276780]
  • Br J Nutr. 2008 Jun;99 Suppl 3:S10-3. [PMID: 18598583]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757